Literature DB >> 10511432

Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease.

J Satoh1, Y Kuroda.   

Abstract

A variety of deletional and point mutations has been identified in the parkin gene on chromosome 6q25.2-27 in patients with autosomal recessive juvenile parkinsonism, a distinct form of familial Parkinson's disease (PD). To study the potential involvement of the parkin gene in development of non-hereditary idiopathic PD, a codon 167 serine/asparagine (167S/N) polymorphism located in its exon 4 was analyzed by direct sequencing in 71 patients with sporadic PD and 109 age-matched non-PD controls. The frequency of either 167S or 167N allele was not statistically different between PD patients and controls, while the frequency of 167S/N heterozygotes was significantly higher in PD patients (62.0% vs 45.9%), compared with that of both 167S/S and 167N/N homozygotes combined (chi2 4.467, p = 0.0346; odds ratio = 1.92, 95% confidence interval = 1.05-3.54). These observations suggest that the heterozygosity at codon 167 in the parkin gene might represent a genetic risk factor for development of sporadic PD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10511432     DOI: 10.1097/00001756-199909090-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

Review 1.  Significance of the parkin gene and protein in understanding Parkinson's disease.

Authors:  Paul S Fishman; George A Oyler
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

2.  Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

Authors:  K Markopoulou; D W Dickson; R D McComb; Z K Wszolek; L Katechalidou; L Avery; M S Stansbury; B A Chase
Journal:  Acta Neuropathol       Date:  2008-04-04       Impact factor: 17.088

3.  Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin.

Authors:  Jerome A Roth; Balakrishnan Ganapathy; Andrew J Ghio
Journal:  Toxicol In Vitro       Date:  2012-07-26       Impact factor: 3.500

4.  Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control.

Authors:  J Brooks; J Ding; J Simon-Sanchez; C Paisan-Ruiz; A B Singleton; S W Scholz
Journal:  J Med Genet       Date:  2009-04-06       Impact factor: 6.318

Review 5.  Genetics of parkin-linked disease.

Authors:  Andrew B West; Nigel T Maidment
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

6.  Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease.

Authors:  A González-Pérez; J Gayán; J Marín; J J Galán; M E Sáez; L M Real; C Antúnez; A Ruiz
Journal:  Neurogenetics       Date:  2009-01-21       Impact factor: 2.660

7.  Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.

Authors:  Ventzislava A Hristova; Steven A Beasley; R Jane Rylett; Gary S Shaw
Journal:  J Biol Chem       Date:  2009-04-01       Impact factor: 5.157

8.  Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease.

Authors:  Vinicius M Fava; Yong Zhong Xu; Guillaume Lettre; Nguyen Van Thuc; Marianna Orlova; Vu Hong Thai; Shao Tao; Nathalie Croteau; Mohamed A Eldeeb; Emma J MacDougall; Geison Cambri; Ramanuj Lahiri; Linda Adams; Edward A Fon; Jean-François Trempe; Aurélie Cobat; Alexandre Alcaïs; Laurent Abel; Erwin Schurr
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-15       Impact factor: 11.205

9.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.

Authors:  Anna Oczkowska; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.